Lv4
770 积分 2021-11-10 加入
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
10小时前
待确认
胆道恶性肿瘤不同解剖部位的流行病学和治疗进展
2天前
已完结
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages
8天前
已完结
Unresectable biliary tract cancer: Current and future systemic therapy
16天前
已完结
Biliary tract cancer
16天前
已完结
Multimodal integration of liquid biopsy and radiology for the noninvasive diagnosis of gallbladder cancer and benign disorders
1个月前
已完结
HER2-Targeted Therapies: Unraveling Their Role in Biliary Tract Cancers
1个月前
已完结
Real-world efficacy of zanidatamab in patients with HER2 positive advanced biliary tract cancers
1个月前
已完结
Conditional Relative Survival of Gallbladder Cancer: A Population-Based Study in a High-Incidence Asian Country from 1999 to 2021
1个月前
已完结
CLO25-099: Lenvatinib With Pembrolizumab in Advanced Biliary Tract Cancer
1个月前
已关闭
皖公网安备34019202002308
